Financials still in play, but rotation towards quality largecaps underway: Jigar Mistry

Jigar Mistry of Buoyant Capital favors healthcare, materials, chemicals, and banking sectors, preferring large-cap private banks over PSU banks. He remains positive on both generic and CDMO pharma segments, dismissing tariff concerns. Mistry believes valuations are elevated, especially for narrative-driven stocks lacking earnings, advocating for a focus on fundamentals over market flows.

Structural concerns loom despite macro strength: Jigar Mistry

Jigar Mistry of Buoyant Capital notes a dichotomy in the Indian market: strong macro indicators contrast with elusive earnings recovery, particularly in mid and small-cap sectors. While banks drive Nifty’s growth, retail behavior shows mixed signals with rising SIPs alongside high cancellation rates. Mistry emphasizes that sustained market levels depend on earnings catching up with strong flows.

Defence stocks detonate in Rs 1.8 lakh crore boom. Is a ceasefire on the charts?

Defence stocks surged by Rs 1.8 lakh crore following Operation Sindoor, driven by strong government orders and Make-in-India momentum. Key players like IdeaForge, Cochin Shipyard, and HAL saw significant gains. While optimism runs high, experts caution on stretched valuations and potential profit booking, urging investors to maintain valuation discipline amid rising geopolitical and defence budget developments.

FIIs pump Rs 23,778 cr into Indian stocks in May. Is more buying seen ahead?

Foreign Institutional Investors (FIIs) have significantly increased their investments in Indian equities, with net purchases of Rs 23,778 crore through May 16, 2025, following a shift in April. This buying momentum is fueled by easing geopolitical tensions, improved global trade relations, and India’s robust growth prospects. Experts anticipate continued FII buying, supported by controlled inflation and expected rate cuts.